accessibility menu, dialog, popup

UserName
Viewing profile as user:

Benzothiadiazoles

Organic heterocyclic compounds that consist of a benzene fused with a thiadiazole ring; thiadiazoles have a five-membered ring that contains two nitrogen atoms, one sulfur atoms, and two double bonds.
Molecular Weight (g/mol) 
  • (1)
  • (2)
  • (3)
  • (3)
  • (4)
  • (1)
  • (5)
  • (2)
  • (1)
  • (9)
  • (2)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (2)
  • (3)
  • (1)
  • (4)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (3)
  • (1)
  • (1)
  • (2)
  • (1)
  • (7)
  • (2)
  • (2)
  • (1)
  • (1)
  • (2)
  • (1)
  • (2)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
Quantity 
  • (27)
  • (3)
  • (3)
  • (3)
  • (1)
  • (13)
  • (9)
  • (9)
  • (21)
Percent Purity 
  • (3)
  • (2)
  • (1)
  • (1)
  • (1)
  • (12)
  • (2)
  • (4)
  • (2)
  • (2)
  • (2)
  • (11)
  • (1)
  • (25)
  • (16)
Physical Form 
  • (32)
  • (3)
  • (2)
Boiling Point 
  • (1)
  • (4)
  • (2)
  • (2)
  • (1)

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

special offers

  • (16)

brands

  • (2)
  • (8)
  • (2)
  • (1)
  • (3)
  • (4)
  • (1)
  • (25)
  • (4)
  • (15)
  • (32)
  • (42)

special interests

  • (32)

Molecular Weight (g/mol)

  • (1)
  • (2)
  • (3)
  • (3)
  • (4)
  • (1)
  • (5)
  • (2)
  • (1)
  • (9)
  • (2)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (2)
  • (3)
  • (1)
  • (4)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (3)
  • (1)
  • (1)
  • (2)
  • (1)
  • (7)
  • (2)
  • (2)
  • (1)
  • (1)
  • (2)
  • (1)
  • (2)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)

Quantity

  • (27)
  • (3)
  • (3)
  • (3)
  • (1)
  • (13)
  • (9)
  • (9)
  • (21)

Percent Purity

  • (3)
  • (2)
  • (1)
  • (1)
  • (1)
  • (12)
  • (2)
  • (4)
  • (2)
  • (2)
  • (2)
  • (11)
  • (1)
  • (25)
  • (16)

Physical Form

  • (32)
  • (3)
  • (2)

Boiling Point

  • (1)
  • (4)
  • (2)
  • (2)
  • (1)

Search Within Results
Keyword Search:
76 – 90 of 108 results
76

eMolecules​ 352018-95-2 | 4-IODO-2,1,3-BENZOTHIADIAZOLE | AstaTech | MFCD02681904 | 262.070 | C6H3IN2S | 95.000 | Ic1cccc2nsnc12 | 1g | 248475689

4-IODO-2,1,3-BENZOTHIADIAZOLE | AstaTech | 352018-95-2 | MFCD02681904 | 262.070 | C6H3IN2S | 95.000 | Ic1cccc2nsnc12 | 1g | 248475689

ENCOMPASS_PREFERRED
77

Medchemexpress LLC FAUC 213 | 337972-47-1 | 99.9% | C18H19ClN4 | 10 MM 1 ML
SDP

FAUC 213 is an orally active and highly selective dopamine D4 receptor complete antagonist with a Ki of 2.2 nM for hD4.4. It has less activity on D2 and D3 receptors (Kis of 3.4 μM, 5.3 μM for hD2, hD3, respectively) and can cross the blood-brain barrier (BBB). FAUC 213 exhibits atypical antipsychotic characteristics.

  • Orally active
  • Highly selective dopamine D4 receptor complete antagonist
  • Ki of 2.2 nM for hD4.4
  • Less activity on D2 and D3 receptors (Kis of 3.4 μM, 5.3 μM for hD2, hD3, respectively)
  • Can cross the blood-brain barrier (BBB)
  • Exhibits atypical antipsychotic characteristics

ENCOMPASS_PREFERRED
78

Apexbio Technology LLC KD 5170 940943-37-3 10mM (in 1mL DMSO)
SDP

KD 5170 (CAS 940943-37-3) is a small-molecule inhibitor targeting histone deacetylases (HDACs) enzymes that catalyze the removal of acetyl groups from histones repressing transcription KD 5170 inhibits HDAC enzyme activity exhibiting distinct inhibitory potency against HDAC isoforms HDAC1 HDAC2 HDAC3 HDAC4 and HDAC6 (IC50 values 0 020 2 0 0 075 0 026 and 0 014 M respectively) In vitro KD 5170 promotes dose-dependent histone hyperacetylation (EC50 25 nM in HeLa cells) and enhances p21WAF1 expression and -tubulin acetylation in HCT-116 cells It has demonstrated antitumor effects reducing tumor growth and increasing histone acetylation in HCT-116 and H929 tumor xenograft mouse models validating its utility in cancer research

ENCOMPASS_PREFERRED
79

Medchemexpress LLC MEDCHEMEXPRESS LLC
SDP

5000759563 2 1 3-BENZOTHIADIAZO 1G

ENCOMPASS_PREFERRED
80

Medchemexpress LLC FAUC 213 | 337972-47-1 | 99.9% | C18H19ClN4 | 50 MG
SDP

FAUC 213 is an orally active and highly selective dopamine D4 receptor complete antagonist with a Ki of 2.2 nM for hD4.4. It shows less activity on D2 and D3 receptors, with Kis of 3.4 μM and 5.3 μM respectively. This compound can cross the blood-brain barrier (BBB) and exhibits atypical antipsychotic characteristics.

  • Highly selective dopamine D4 receptor complete antagonist
  • Orally active
  • Crosses the blood-brain barrier (BBB)
  • Exhibits atypical antipsychotic characteristics
  • Inhibits p5-HT1 (Ki=1.2 μM), p5-HT2 (Ki=0.52 μM), and pα1 (Ki=0.27 μM)
  • Significantly reduces amphetamine-induced locomotor hyperactivity at 30 mg/kg
  • Restores prepulse inhibition reduction caused by apomorphine treatment at 30 mg/kg

ENCOMPASS_PREFERRED
81

eMolecules​ 352018-95-2 | 4-IODO-2,1,3-BENZOTHIADIAZOLE | AstaTech | MFCD02681904 | 262.070 | C6H3IN2S | 95.000 | Ic1cccc2nsnc12 | 5g | 277517082

4-IODO-2,1,3-BENZOTHIADIAZOLE | AstaTech | 352018-95-2 | MFCD02681904 | 262.070 | C6H3IN2S | 95.000 | Ic1cccc2nsnc12 | 5g | 277517082

ENCOMPASS_PREFERRED
82

AMBEED 1-METHYLSULFONYL-1H-BENZO D 12

NC3373228 1-METHYLSULFONYL-1H-BENZO D 12

ENCOMPASS_PREFERRED
83

Medchemexpress LLC S-[2-[6-[[4-[3-(dimethylamino)propoxy]phenyl]sulfonylamino]-3-pyridinyl]-2-oxoethyl] ethanethioate | 940943-37-3 | MFCD19690928 | >96.0% | 451.6 g/mol | C20H25N3O5S2 | 50 MG
SDP

KD 5170 is a mercaptoketone-based pan inhibitor of histone deacetylases (HDACs) that exhibits broad-spectrum antitumor activity in vitro and in vivo. It is provided as a solid research reagent for biochemical and cellular studies of HDAC inhibition, apoptosis, and cell-cycle regulation.

  • Pan-HDAC inhibitor active against multiple HDAC isoforms.
  • Demonstrates potent biochemical and cellular activity.
  • Validated for in vitro and in vivo antitumor studies.
  • Supplied as a solid with high purity (>96%).
  • Chemical formula C20H25N3O5S2; molecular weight ~451.6 g/mol.
  • Intended for research use in oncology and epigenetics.

ENCOMPASS_PREFERRED
84

eMolecules​ 65858-50-6 | 5-(Bromomethyl)-2,1,3-benzothiadiazole | Combi-Blocks | MFCD00544836 | 229.100 | C7H5BrN2S | 97.000 | BrCc1ccc2nsnc2c1 | 5g | 342867659

5-(Bromomethyl)-2,1,3-benzothiadiazole | Combi-Blocks | 65858-50-6 | MFCD00544836 | 229.100 | C7H5BrN2S | 97.000 | BrCc1ccc2nsnc2c1 | 5g | 342867659

ENCOMPASS_PREFERRED
85

Medchemexpress LLC 2-[[4-(4-chlorophenyl)-1-piperazinyl]methyl]-pyrazolo[1,5-a]pyridine | 337972-47-1 | MFCD06798338 | 99.8% | C18H19ClN4 | 10MG
SDP

FAUC 213 is an orally active, highly selective dopamine D4 receptor complete antagonist used as a research compound in neuroscience and pharmacology studies. It shows high affinity for the human D4.4 receptor, reduced activity at D2 and D3 receptors, and can cross the blood-brain barrier.

  • High affinity for dopamine D4 receptor (Ki = 2.2 nM for hD4.4).
  • Low activity at D2 and D3 receptors (Ki = 3.4 μM and 5.3 μM, respectively).
  • Orally active and brain penetrant.
  • Useful as a tool to study dopaminergic signaling and atypical antipsychotic profiles.
  • Research use only; not for human or clinical use.

ENCOMPASS_PREFERRED
86

Medchemexpress LLC Ethanethioic acid S-[2-[6-[[[4-[3-(dimethylamino)propoxy]phenyl]sulfonyl]amino]-3-pyridinyl]-2-oxoet | 940943-37-3 | 98.1% | 451.56 | C20H25N3O5S2 | 5 MG
SDP

KD 5170 is a mercaptoketone-based pan inhibitor of histone deacetylases (HDACs) that exhibits broad-spectrum antitumor activity in vitro and in vivo. It is supplied as a research compound with characterized purity and physicochemical properties for preclinical studies.

  • Pan inhibitor of histone deacetylases (HDACs).
  • Demonstrated broad-spectrum antitumor activity in vitro and in vivo.
  • High purity suitable for research applications (≈98.1%).
  • Soluble in DMSO at high concentration (100 mg/mL) for in vitro assays.
  • Recommended solid storage at 4°C; solutions stable at -80°C (6 months) or -20°C (1 month).
  • Molecular formula C20H25N3O5S2 and molecular weight 451.56 aid compound handling and dosing.

ENCOMPASS_PREFERRED
87

Medchemexpress LLC FAUC 213 | 337972-47-1 | 99.9% | C18H19ClN4 | 100 MG
SDP

FAUC 213 is an orally active and highly selective dopamine D4 receptor complete antagonist. It demonstrates a Ki of 2.2 nM for the hD4.4 receptor and exhibits less activity on D2 and D3 receptors. This compound can cross the blood-brain barrier (BBB) and shows atypical antipsychotic characteristics.

  • Orally active and highly selective dopamine D4 receptor complete antagonist
  • Ki of 2.2 nM for hD4.4 receptor
  • Crosses the blood-brain barrier (BBB)
  • Exhibits atypical antipsychotic characteristics
  • Inhibits p5-HT1 (Ki=1.2 μM), p5-HT2 (Ki=0.52 μM), pα1 (Ki=0.27 μM)

ENCOMPASS_PREFERRED
88

Medchemexpress LLC 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine | 337972-47-1 | MFCD06798338 | 99.9% | 326.82 g/mol | C18H19ClN4 | 5 MG
SDP

FAUC 213 is a small-molecule research compound acting as a highly selective dopamine D4 receptor full antagonist. It is supplied as a solid for pharmacology studies and analytical use, with defined molecular properties and high reported purity suitable for reproducible in vitro and in vivo experiments.

  • Highly selective dopamine D4 receptor antagonist for receptor pharmacology studies.
  • High purity (~99.9%) for consistent experimental results.
  • Available in milligram-scale quantities to support screening and dose-ranging studies.
  • Well-characterized molecular formula and weight for formulation and calculations.
  • Offered as solid and as a DMSO solution option for assay-ready formats.

ENCOMPASS_PREFERRED
89

Medchemexpress LLC Tet-213 TFA | 99.9% | 1704.92 | 10 MG
SDP

Tet-213 TFA is an antimicrobial peptide with broad-spectrum antibacterial activity, which can promote infected wound repair.

  • Broad-spectrum antibacterial activity
  • Promotes infected wound repair
  • Shows significant antibacterial activity on 80% (16 of 20 strains) of *S. aureus* clinical isolates
  • Strongly reduces the growth and biofilm formation of *S. aureus*

ENCOMPASS_PREFERRED
90

Matrix Scientific 4,7-DIBROMO-2,1,3-BENZOTHIAD-5

4,7-dibromo-2,1,3-benzothiadiazole Mf C6h2br2n2s Mw 293.98 Cas 15155-41-6 Mdl MFCD00658844

ENCOMPASS_PREFERRED